DiscoverTranslating Proteomics
Translating Proteomics
Claim Ownership

Translating Proteomics

Author: Nautilus Biotechnology

Subscribed: 16Played: 100
Share

Description

‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery, drug development, food and energy security, and a range of other timely topics. Hosts Parag Mallick Ph.D. and Andreas Huhmer Ph.D. of Nautilus Biotechnology aim to share their perspectives on important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.
31 Episodes
Reverse
Unlike “globular” proteins that adopt stable structures that are relatively easy to analyze, intrinsically disordered proteins adopt many context-dependent shapes. These shapes may drive diverse functions, but they are also difficult to capture and study. This represents a large gap in our understanding of biology, given that most proteins may have intrinsically disordered regions. Thankfully, researchers like Professor Priyanka Joshi, Ph.D., from Georgetown University have devoted themselves to studying intrinsically disordered proteins and are developing new approaches and leveraging new technologies like the Nautilus Voyager™ Platform to discover how their dynamic structures influence biological function. Because intrinsically disordered proteins often aggregate in disease, this work is not only essential to our understanding of biology but may also enable the development of effective biomarkers and treatments for diseases like Alzheimer’s.Parag interviews Professor Joshi on this episode of Translating Proteomics to discover:What intrinsically disordered proteins areHow intrinsically disordered proteins influence biology and why they’re hard to studyHow the recently announced SEEDS Consortium is studying intrinsically disordered proteinsChapters:00:00 – Introduction to Prof. Priyanka Joshi, Ph.D.04:35 – What are intrinsically disordered proteins (IDPs)?11:41 – When do intrinsically disordered proteins go bad in disease?23:02 – Archetypal Intrinsically disordered proteins – c-Myc/Max, p53, and Tau38:26 – Barriers to solving the problems associated with intrinsically disordered proteins43:30 – The future of intrinsically disordered protein research and introducing the SEEDS ConsortiumAdditional resources featured in the episode:https://pubmed.ncbi.nlm.nih.gov/26923286/Joshi, Priyanka et al. “A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.” ACS combinatorial science vol. 18,3 (2016): 144-53. doi:10.1021/acscombsci.5b00129Priyanka’s 2016 work developing small-molecule libraries to target IDPs https://www.georgetown.edu/news/georgetown-and-buck-institute-awarded-up-to-51-7m-to-predict-protein-changes-linked-to-alzheimers-and-some-cancers/Georgetown University press release covering the SEEDS Consortiumhttps://investors.nautilus.bio/news-releases/news-release-details/nautilus-measure-proteoforms-driving-alzheimers-disease-andNautilus Biotechnology press release covering its involvement in the SEEDS Consortium
Professor Brendan Keating’s lab focuses on “advancing the field of organ transplantation” and employs multiomic techniques to improve outcomes for both allo- (human to human) and xeno- (animal to human) transplantation. He’s using multiomics to better understand the mechanisms of rejection and acceptance with a particular focus on immunologic barriers in cross-species transplantation. Professor Keating joins Translating Proteomics to discuss:The current state of transplant medicine including xenotransplantationHow multiomics is changing transplant medicineThe future of transplant medicine.Chapters:00:00 – Introduction05:00 - Transplantation Today: Outcomes, Challenges, and the Organ Shortage10:06 - From Genetics to Multiomics19:53 - Xenotransplantation deep dive30:42 - Ten‑Year Vision: Transplants and the Role of Multiomics
Translating Proteomics hosts Parag Mallick and Andreas Huhmer discuss our new Nature Methods paper, “Large-scale single-molecule analysis of tau proteoforms.” This publication describes how the Nautilus Voyager™ Platform can be used to quantify proteoforms derived from the neurodegeneration-associated tau protein. These proteoforms are defined by their unique combinations of post-translational modifications and isoform specific sequences. They may make powerful next-generation biomarkers or drug targets, but few technologies can measure them today.In the episode, Parag and Andreas discuss:What proteoforms are and why it’s critical to study them to understand biology.How the Nautilus Voyager™ Platform quantifies proteoforms.The key findings from the tau proteoform analyses in the paper.Potential applications of these findings.The Nautilus Voyager™ Platform as a powerful foundational technology.Access our video series exploring the paper in more detail.
On the latest episode of the Translating Proteomics podcast, Nautilus VP of Scientific Engagement and proteomics industry expert Sheri Wilcox joins hosts Parag Mallick and Andreas Huhmer for a thought-provoking discussion of their proteomics "hot takes.”Each “hot take” is a provocative opinion on a topic in proteomics. Specifically, they cover:Insufficient biological validation is one of the biggest problems in proteomics.Antibody validation remains a distributed, inconsistent, lab-by-lab responsibility, and this model for validation may not be sustainable going forward.AI cell models are overhyped.Check out the episode for deep explorations of each of these hot takes and their potential remedies.After listening, be sure to let us know whether you agree, disagree, or have your own hot take to share!
Professor Olga Vitek has a deep understanding of statistics, machine learning, and computational biology. She puts her know-how to work to develop computational tools enabling high-quality proteomic analysis and systems biology approaches. She hopes to apply these tools to the quantitative analysis of large-scale mass spectrometry-based investigations and thereby advance our understanding of organismal function. In this episode, Parag and Professor Vitek discuss:Why statistics is important for experimental designHow statistics and AI can help researchers understand biologyGaps keeping us from using AI and statistics to their maximum potential in biologyResourcesStatistical methods for studies of biomolecular systems websiteOlga’s personal lab websiteBeyond protein lists: AI-assisted interpretation of proteomic investigations in the context of evolving scientific knowledgeGyori and Vitek, 2024 discuss how AI can be used to interpret proteomics data and its biological meaning.A Bayesian Active Learning Experimental Design for Inferring Signaling NetworksNess et al., 2018 show how statistical methods can guide the selection of experiments that optimally enhance understanding
loading
Comments